RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.04+0.09 (+8.91%)
Close on Nov 17, 2026Market cap $46.93MP/E –Yield –
RenovoRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
RenovoRx's price to sales ratio was 27.9× on Nov 11, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 27.9× | – |
See a number that looks wrong?